Stock 2367 GIANT BIOGENE HOLDING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Giant Biogene Holding Co., Ltd.

Equities

2367

KYG3887G1091

Personal Products

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
49.45 HKD +0.20% Intraday chart for Giant Biogene Holding Co., Ltd. -1.10% +38.90%
May. 27 Giant Biogene Places 33.2 Million Shares for About HK$1.63 MT
Apr. 30 Giant Biogene’s Profit Up 47% in 2023 MT

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 28,963 31,581 46,217 - -
Enterprise Value (EV) 2 27,686 29,210 42,182 40,712 38,927
P/E ratio 30 x 22.2 x 25.5 x 20.1 x 16.4 x
Yield - 1.34% 1.36% 1.75% 2.12%
Capitalization / Revenue 12.2 x 8.96 x 9.86 x 7.68 x 6.18 x
EV / Revenue 11.7 x 8.29 x 9 x 6.76 x 5.2 x
EV / EBITDA 23.8 x 17.8 x 20.4 x 15.8 x 12.4 x
EV / FCF 35.5 x 20.6 x 30.1 x 20.5 x 16.4 x
FCF Yield 2.81% 4.87% 3.33% 4.88% 6.1%
Price to Book 10.7 x 7.38 x 8.35 x 6.52 x 5.22 x
Nbr of stocks (in thousands) 976,000 976,000 1,009,220 - -
Reference price 3 33.60 35.60 49.45 49.45 49.45
Announcement Date 3/27/23 3/25/24 - - -
1HKD in Million2CNY in Million3HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 2,364 3,524 4,689 6,019 7,480
EBITDA 1 1,161 1,645 2,067 2,577 3,133
EBIT 1 1,134 1,611 2,024 2,592 3,225
Operating Margin 47.95% 45.71% 43.18% 43.07% 43.11%
Earnings before Tax (EBT) 1 1,178 1,745 2,118 2,696 3,314
Net income 1 1,002 1,452 1,794 2,273 2,783
Net margin 42.38% 41.19% 38.27% 37.76% 37.21%
EPS 2 1.120 1.605 1.941 2.466 3.020
Free Cash Flow 1 779 1,421 1,403 1,988 2,374
FCF margin 32.95% 40.33% 29.92% 33.03% 31.73%
FCF Conversion (EBITDA) 67.1% 86.38% 67.86% 77.14% 75.76%
FCF Conversion (Net income) 77.74% 97.89% 78.19% 87.47% 85.28%
Dividend per Share 2 - 0.4772 0.6742 0.8632 1.050
Announcement Date 3/27/23 3/25/24 - - -
1CNY in Million2HKD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 1,641 1,606 1,918 2,199 2,582
EBITDA - - - - -
EBIT 1 771.9 714.3 896.7 900.6 1,057
Operating Margin 47.03% 44.49% 46.74% 40.95% 40.95%
Earnings before Tax (EBT) - - 969.5 - -
Net income - - 784.8 - -
Net margin - - 40.91% - -
EPS - - - - -
Dividend per Share - - - - -
Announcement Date 3/27/23 8/28/23 3/25/24 - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - - - - -
Net Cash position 1 1,276 2,371 4,034 5,505 7,289
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 779 1,421 1,403 1,988 2,374
ROE (net income / shareholders' equity) 54.9% 40.8% 34.7% 34.1% 32.5%
ROA (Net income/ Total Assets) 19.2% 36.2% 30.9% 30.6% 29.9%
Assets 1 5,225 4,009 5,803 7,418 9,314
Book Value Per Share 2 3.150 4.820 5.920 7.580 9.480
Cash Flow per Share 2 1.030 1.810 2.300 3.010 3.980
Capex 1 153 226 189 166 179
Capex / Sales 6.46% 6.42% 4.03% 2.76% 2.39%
Announcement Date 3/27/23 3/25/24 - - -
1CNY in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Giant Biogene Holding Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
49.45 HKD
Average target price
55.63 HKD
Spread / Average Target
+12.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Personal Products

1st Jan change Capi.
GIANT BIOGENE HOLDING CO., LTD. Stock Giant Biogene Holding Co., Ltd.
+38.90% 6.38B
PROCTER & GAMBLE COMPANY Stock Procter & Gamble Company
+12.28% 388B
UNILEVER PLC Stock Unilever PLC
+12.61% 136B
COLGATE-PALMOLIVE COMPANY Stock Colgate-Palmolive Company
+16.62% 76.27B
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-12.57% 65.56B
ESTEE LAUDER Stock Estee Lauder
-15.65% 44.23B
KENVUE INC. Stock Kenvue Inc.
-10.36% 36.96B
BEIERSDORF Stock Beiersdorf
+6.37% 35.04B
ESSITY AB Stock Essity AB
+7.80% 18.02B
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+12.30% 15.57B
Other Personal Products
  1. Stock Market
  2. Equities
  3. 2367 Stock
  4. Financials Giant Biogene Holding Co., Ltd.